TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Rainbow Childrens Medicare Ltd.

RAINBOW on NSE · 19 Nov 2026

NIFTY 500

1,240.80 ▼ -1.37 % on the day

Overview Technical Risk & rank Results Accounts Filings Guidance & governance

Filings

39 filings of RAINBOW since January 2025.

board outcome 11, presentation 9, transcript 8, acquisition 4, credit rating 3, results 2

FiledTypeSubject
06 Nov 2026transcript
Capex, Guidance, Results
Rainbow Children's Medicare Limited has informed the Exchange about Transcript of Earnings Conference Call on Unaudited Financial Results for the quarter and half year ended September 30, 2026.
AI summary

Rainbow Children's Medicare filed the transcript of its Q2 FY27 earnings conference call held on November 2, 2026, covering unaudited results for the quarter and half year ended September 30, 2026.

Management reported Q2 operating revenue of INR 548 crores (up 23.2% year-on-year), EBITDA of INR 170 crores (up 14.2%, margin 31%) and PAT of INR 83.9 crores (up 10.9%).

For H1 FY27, management reported revenue of INR 1,018 crores (up 27.6%), EBITDA of INR 304.6 crores (up 20.6%, margin 29.9%) and PAT of INR 146.4 crores (up 13.1%).

Management said cash, fixed deposits and mutual fund investments totalled INR 542.8 crores as of September 30, 2026, and Q2 capex was INR 81.9 crores.

Management said it expects about 0.5% margin impact from new capacity additions in a quarter and sees ARPOB and ARPP growth in the range of 6% to 8%.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
31 Oct 2026presentation
Results
Rainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation
AI summary

Rainbow Children's Medicare Limited filed its earnings presentation on unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026 (Q2 FY27), to be shared with analysts and investors.

Q2 FY27 operational KPIs versus Q2 FY26: IP discharges 27,595 vs 4,27,595? (printed as 5,07,114 total OP consultations, up 19% from 4,27,595 in Q2 FY26); deliveries 5,719 (+20%); occupancy 49.2% vs 52.0% (-5%); ARPOB Rs 63,413 vs Rs 57,396 (+10%); ALOS 2.64 days vs 2.73 days (-3%).

Operational beds rose 15% to 28,380 from 24,6xx; capacity beds were 32,706 in Q2 FY27 versus 26,886 in Q1 FY27 per the printed comparison.

Rainbow Nellore and Rainbow Guntur commenced on September 1, 2026, and Rainbow HRBR commenced on May 1, 2026 with 60 capacity beds.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
31 Oct 2026board outcome
Acquisition, Capex, Results
Rainbow Childrens Medicare Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results for Quarter and Half Year Ended September 30, 2026
AI summary

Board of Rainbow Children's Medicare Limited approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026 at its meeting on October 31, 2026; Limited Review Report by S.R. Batliboi & Associates LLP is annexed.

Standalone revenue from operations was Rs. 4,869.9 million for the quarter ended September 30, 2026 (Rs. 4,084.96 million in the year-ago quarter) and Rs. 8,975.38 million for the half year.

Standalone profit after tax was Rs. 761.61 million for the quarter (Rs. 527.06 million in the year-ago quarter) and Rs. 1,277.99 million for the half year; basic EPS was Rs. 7.41 for the quarter.

On July 29, 2026, the company acquired a 64% partnership interest in Super Prime Medical Care LLP for Rs. 185.10 million upfront, with Rs. 13.30 million contingent, total Rs. 198.40 million; control was taken from August 14, 2026.

On July 29, 2026, the company diluted 24% of its stake in Rainbow Women & Children's Hospital Private Limited, which is developing a new hospital at Malad, Mumbai.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Sep 2026credit rating
Rating
Rainbow Childrens Medicare Limited has informed the Exchange about Credit Rating
AI summary

Rainbow Children's Medicare Limited filed an intimation under SEBI LODR Regulation 30 on September 29, 2026 regarding a credit rating action.

ICRA Limited has reaffirmed the company's issuer rating at [ICRA]AA (Stable).

The filing states this is a reaffirmation of the rating assigned last time.

The rating will become due for surveillance within one year from the date of the rating communication letter.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
23 Sep 2026board outcome
Legal, Management change
Rainbow Childrens Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on September 23, 2026.
AI summary

Rainbow Children's Medicare Limited filed the outcome of its board meeting held on September 23, 2026.

The board appointed Mr. Sudarshan Patodia as Chief Financial Officer and Key Managerial Personnel, designated Group Chief Financial Officer, effective September 23, 2026.

Mr. Patodia is a Chartered Accountant with nearly two decades of finance experience in healthcare, retail and FMCG, previously CFO of New Delhi Centre for Sight Limited and Vice President – Finance at Vishal Mega Mart.

The board also approved amendments to the Policy on Determination of Materiality of Events / Information.

The board meeting commenced at 5:30 PM and concluded at 5:45 PM.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
04 Aug 2026transcript
Acquisition, Capex, Guidance, Results
Rainbow Childrens Medicare Limited has informed the Exchange about Transcript
AI summary

Rainbow Children's Medicare filed the transcript of its Q1 FY27 investor/earnings call held on July 31, 2026, for the quarter ended June 30, 2026.

Management reported operating revenue of INR 470 crores, up 33% year-on-year, and EBITDA of INR 134.6 crores, up 30% year-on-year, with an EBITDA margin of 28.6%.

Profit after tax was INR 62.5 crores, up 16% year-on-year; capital expenditure during the quarter was about INR 56 crores.

Management said it plans to add 2,500 beds over five years to reach 5,000 beds, with estimated capex of about INR 2,200 crores, and signed a definitive agreement for a 100-bed hospital in Malad, Mumbai, expected to start in Q1 FY28.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
30 Jul 2026presentation
Acquisition, Capex, Results
Rainbow Childrens Medicare Limited has informed the Exchange about Presentation
AI summary

Rainbow Children's Medicare Limited filed an earnings presentation on its un-audited standalone and consolidated financial results for the quarter ended June 30, 2026 (Q1 FY26-27), to be shared with analysts and investors.

The pages provided show company background: 24 hospitals across 9 cities, 1,075+ capacity beds (per the network slide), 5 out-patient clinics and 6.9k+ doctors... (figures not clearly legible in the OCR text).

The presentation notes JCI re-accreditation for Rainbow Children's Hospital Banjara Hills and BirthRight Fertility, Kondapur, Hyderabad.

The company lists 2025-2026 acquisitions of Prashanthi Hospital (Warangal) and Pratiksha Hospital (Guwahati), plus new spoke hospitals at Rajahmundry, Electronic City and HRBR, Bengaluru.

The pages provided do not include the financial figures for the quarter.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
30 Jul 2026presentation
Results
Rainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation
AI summary

Rainbow Children's Medicare Limited filed an earnings presentation on its un-audited standalone and consolidated financial results for the quarter ended June 30, 2026 (Q1 FY26-27), to be shared with analysts and investors.

The pages provided do not include the financial figures, so revenue, profit and other results are not stated in this excerpt.

The company describes itself as the country's largest pediatric hospital chain with 24 hospitals across 9 cities.

Recent developments listed include the acquisition of Prashanthi Hospital, Warangal and Pratiksha Hospital, Guwahati, and the commencement of spoke hospitals at Rajahmundry, Electronic City and HRBR, Bengaluru (2025-2026).

The presentation reports 1,075+ capacity beds, 4.9k+ in-patient admissions, 410k+ out-patient visits and 26.8k+ deliveries for Q1 FY27.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
30 Jul 2026board outcome
Management change, Results
Rainbow Childrens Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on July 30, 2026.
AI summary

Outcome of board meeting held July 30, 2026: board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a limited review report from statutory auditors S.R. Batliboi & Associates LLP.

Standalone revenue from operations for Q1 FY27 was Rs 4,105.47 million, against Rs 3,347.48 million a year earlier; profit after tax was Rs 527.06 million... total income Rs 4,233.04 million.

Standalone profit after tax for the quarter was Rs 527.06 million, against Rs 593.05 million in the year-ago quarter... basic and diluted EPS Rs 5.20 (not annualised).

Board elevated Mr. Anshuman Jaiswal from Group Head – Legal to Chief Legal Officer and designated him a Senior Management Personnel with immediate effect.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
30 Jul 2026board outcome
Management change, Results
Rainbow Childrens Medicare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2026.
AI summary

Board of Rainbow Children's Medicare Limited approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with limited review report from S.R. Batliboi & Associates LLP.

Standalone revenue from operations for Q1 FY27 was Rs 4,105.47 million, up from Rs 3,347.48 million a year earlier; profit after tax was Rs 527.06 million versus Rs 593.05 million...

Standalone profit after tax for the quarter was Rs 527.06 million (quarter ended March 31, 2026: Rs 593.05 million); basic EPS was Rs 5.20.

Board elevated Mr. Anshuman Jaiswal from Group Head – Legal to Chief Legal Officer and designated him Senior Management Personnel with immediate effect.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Jul 2026acquisition
Acquisition, Capex
Rainbow Childrens Medicare Limited has informed the Exchange about Acquisition
AI summary

Rainbow Children's Medicare Limited executed a Partnership Interest and Contribution Transfer Agreement with the partners of Super Prime Medical Care LLP and the LLP to acquire 64% partnership interest and corresponding capital contribution.

Aggregate consideration is ₹19.84 Cr, paid in cash, subject to adjustments; the LLP becomes a subsidiary on completion.

The LLP operates a 70-bed hospital and allied healthcare services, a children's hospital at Nellore, Andhra Pradesh.

The LLP reported unaudited provisional turnover of ₹9.44 Cr for FY 2025-26 (₹3.75 Cr for FY 2024-25).

Completion is expected on or before August 31, 2026; the company plans to add about 30 beds to the hospital.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Jul 2026acquisition
Acquisition, Capex
Rainbow Childrens Medicare Limited has informed the Exchange about Acquisition
AI summary

Rainbow Children's Medicare Limited filed an intimation that it has executed definitive transaction documents, including a Shareholders' Agreement, for a new children's and women's hospital at Malad, Mumbai, through its wholly owned subsidiary Rainbow Women & Children's Hospital Private Limited (RWCHPL).

The estimated project cost is approximately ₹90 Crore, with about ₹68.4 Crore to be contributed by the Company and financing through internal accruals.

Fountainhead TCHM Healthcare LLP is to acquire a 24% equity stake in RWCHPL, leaving the Company with 76% and continued control, so RWCHPL remains a subsidiary.

The 100-bed capacity addition is expected to be commissioned by Q1 FY27-28, subject to approvals and construction; the Company's existing capacity is 2,435 beds at 46.3% utilisation.

The buyer's consideration for the stake is stated as ₹24,000, with completion expected on or before August 31, 2026.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
01 Jun 2026transcript
Acquisition, Capex, Guidance, Results
Rainbow Childrens Medicare Limited has informed the Exchange about Transcript
AI summary

Rainbow Children's Medicare filed the transcript of its Q4 & FY26 investor call held on May 25, 2026 (link to the transcript on the company website provided).

Management said Q4 FY26 revenue was INR 459.9 crores (up 24% YoY), EBITDA INR 144.7 crores (up 26%), PAT INR 78.2 crores (up 38%; about 17% excluding deferred tax adjustment), and occupancy 45.3%.

For FY26, management reported revenue of INR 1,703 crores (up 12%), EBITDA of INR 544 crores (up 11%), PAT of INR 282 crores (up 15.3%), and capex of about INR 217 crores.

Management said the company has no debt, holds about INR 600 crores in cash and cash equivalents, and expects to fund about 900 beds of projects from internal accruals; it targets 20% growth for the current year while maintaining margins.

Management also outlined projects (Coimbatore, Gurugram, Pune, Bengaluru and Indore) and said it will look at acquisitions of assets with at least 50 operational beds and plans to share a new-geography growth plan within three months.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
23 May 2026presentation
Results
Rainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation
AI summary

Rainbow Children's Medicare Limited filed its earnings presentation on the audited standalone and consolidated results for the quarter and financial year ended March 31, 2026, to be shared with analysts and investors.

The filed pages show a company overview: the country's largest pediatric hospital chain with 241 hospitals across 9 cities (including HRBR Hospital, Bengaluru), per the company profile.

Pages also cite 1,050+ doctors, 24 cities/states footprint details, 19k+ capacity beds, 1,598k+ in-patient admissions, 2,435 deliveries and 104k+ out-patient visits (FY26 figures as footnoted).

The extracted pages contain no financial results figures (revenue, profit or margins), dividend, or outlook.

Recent milestones listed include acquisitions of Prashanthi Hospital, Warangal and Pratiksha Hospital, Guwahati, and the start of spoke hospitals at Rajahmundry, Electronic City and HRBR, Bengaluru in 2025-2026.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
23 May 2026dividend
Dividend / buy-back, Legal, Management change, Results
Rainbow Childrens Medicare Limited has informed the Exchange that Board of Directors at its meeting held on May 23, 2026, recommended Final Dividend of Rs. 3.5 per equity share.
AI summary

Outcome of board meeting held May 23, 2026: audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 approved, with unmodified audit opinion from S.R. Batliboi & Associates LLP.

Final dividend of ₹3.5 per equity share (35% on face value of ₹10) recommended for FY 2025-26, subject to shareholder approval at the 28th AGM; to be paid within 30 days of the AGM.

28th AGM fixed for July 29, 2026 via VC/OAVM; record date for final dividend and AGM set as July 21, 2026.

Board approved re-appointment of Dr. Ramesh Kancharla as Chairman and Managing Director and Dr. Dinesh Kumar Chirla as Whole Time Director, each for five years from August 11, 2026 to August 10, 2031, subject to shareholder approval.

Board approved second-term re-appointments of independent directors Mr. Santanu Mukherjee (October 22, 2026 to October 21, 2031) and Ms. Sundari R. Pisupati (September 16, 2026 to September 15, 2031), and re-appointment of M/s. Lavanya & Associates LLP as cost auditors for FY 2026-27.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
23 May 2026board outcome
Dividend / buy-back, Legal, Management change, Results
Rainbow Childrens Medicare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
AI summary

Board of Rainbow Children's Medicare Limited, meeting held May 23, 2026, approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, with unmodified audit opinions from S.R. Batliboi & Associates LLP.

Board recommended a final dividend of ₹3.5 per equity share (35% on face value of ₹10) for FY 2025-26, subject to shareholder approval at the 28th AGM; record date set as July 21, 2026.

28th AGM to be held on July 29, 2026 via video conferencing / other audio-visual means.

Board approved re-appointment of Dr. Ramesh Kancharla as Chairman and Managing Director and Dr. Dinesh Kumar Chirla as Whole Time Director, each for five years from August 11, 2026 to August 10, 2031, subject to shareholder approval.

Board approved re-appointment of Mr. Santanu Mukherjee (from October 22, 2026) and Ms. Sundari R. Pisupati (from September 16, 2026) as Independent Directors for a second five-year term, subject to shareholder approval; also re-appointed M/s. Lavanya & Associates LLP as Cost Auditors for FY 2026-27.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
03 Feb 2026transcript
Capex, Guidance, Management change, Results
Rainbow Childrens Medicare Limited has informed the Exchange about Transcript
AI summary

Rainbow Children's Medicare filed the transcript of its Q3 FY26 and 9M FY26 investor call held on January 29, 2026.

Management reported Q3 FY26 revenue of INR445.4 crores (up 12%), EBITDA of INR147 crores (up 9%) and PAT of INR73.9 crores (up 7%); occupancy was 47.2% for the quarter.

For 9M FY26, revenue was INR1,243 crores (up 9%), EBITDA close to INR400 crores (up 6%) and PAT INR203.3 crores (up 8.3%).

Management said it aims to lift occupancy to around 55%-60% and expects ARPP to grow about 5%-7% CAGR over the long term.

Management said cash stood at INR579 crores as of December 31, 2025 and that planned capex will be funded from internal resources.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
28 Jan 2026presentation
Results
Rainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation
AI summary

Rainbow Children's Medicare filed an earnings presentation on its unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025, to be shared with analysts and investors.

The pages provided contain the disclaimer, a JCI accreditation note, the company's history and an operational footprint (231 hospitals across 9 cities, 14k+ capacity beds, 1,174k+ 9M FY26 in-patient admissions, 2,375 doctors).

The pages provided do not include the financial figures for the quarter or nine months.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
28 Jan 2026board outcome
Dividend / buy-back, Management change, Results
Rainbow Childrens Medicare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
AI summary

Rainbow Children's Medicare Limited filed the outcome of its board meeting held January 28, 2026, approving unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, with a limited review report from statutory auditors S.R. Batliboi & Associates LLP.

Standalone revenue from operations for the quarter ended December 31, 2025 was Rs. 3,943.52 million; profit after tax was Rs. 658.24 million; basic EPS was Rs. 6.48.

For the nine months ended December 31, 2025, standalone revenue from operations was Rs. 11,375.96 million and profit after tax was Rs. 1,907.11 million.

The board also noted the grant of 100,000 stock options under the ESOP 2025 scheme on January 28, 2026, and the appointment of Mr. Abrarali Dalal as CEO effective January 20, 2026.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
20 Nov 2025transcript
Acquisition, Capex, Guidance, Management change, Results
Rainbow Childrens Medicare Limited has informed the Exchange about Transcript
AI summary

Rainbow Children's Medicare filed the transcript of its Q2 & H1 FY26 investor call held on November 14, 2025.

Management reported Q2 FY26 operating revenue of Rs.444.8 Crores (up 6.5% YoY), EBITDA of Rs.148.8 Crores (up 1.2%, margin 33.5%) and PAT of Rs.75.6 Crores (down 4.3%).

For H1 FY26, management reported revenue of Rs.797.7 Crores (up 6.7%), EBITDA of Rs.252.5 Crores (up 4.9%) and PAT of Rs.129.4 Crores (up 9%).

Management said softer paediatric volumes and early festive season compressed admissions, but expects normalisation in coming quarters; it also announced Abrarali Dalal as Group CEO effective January 20, 2026.

Management said net cash was Rs.555.8 Crores as of September 30, 2025, and planned capex will be funded through internal accruals without debt.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
13 Nov 2025presentation
Results
Rainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation
AI summary

Rainbow Children's Medicare filed its earnings presentation on unaudited standalone and consolidated results for the quarter and half year ended September 30, 2025, to be shared with analysts and investors.

The presentation's visible pages cover the company's JCI accreditations, including its Hyderabad and Bengaluru flagship hubs and the BirthRight Fertility centre in Kondapur, Hyderabad.

The company is described as the country's largest pediatric hospital chain with 221 hospitals across 9 cities, including the 2025 acquisitions of Prashanthi Hospital, Warangal and Pratiksha Hospital, Guwahati.

The footprint slide shows 22 states/cities, 1,000+ doctors, 5 hospitals... (figures as printed in the OCR text, partly garbled).

The text provided does not include the financial figures for the quarter or half year.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
13 Nov 2025board outcome
Management change, Results
Rainbow Childrens Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
AI summary

Rainbow Children's Medicare Limited filed the outcome of its board meeting held November 13, 2025, approving unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025.

Standalone revenue from operations for Q2 FY26 was Rs 4,084.96 million, against Rs 4,039.25 million in the year-ago quarter and Rs 3,347.48 million in the previous quarter (June 30, 2025).

Standalone profit after tax for the quarter ended September 30, 2025 was Rs 731.67 million, against Rs 773.44 million a year earlier; basic EPS was Rs 7.20.

For the half year ended September 30, 2025, standalone revenue from operations was Rs 7,432.44 million and profit after tax was Rs 1,248.87 million.

The board appointed Mr. Abrarali Dalal as Chief Executive Officer (Key Managerial Personnel) with effect from January 20, 2026.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
14 Aug 2025credit rating
Rating
Rainbow Childrens Medicare Limited has informed the Exchange about Credit Rating
AI summary

Rainbow Children's Medicare Limited filed a Regulation 30 disclosure on August 14, 2025 forwarding a credit rating letter received that day from ICRA Limited.

ICRA reaffirmed the company's issuer rating at [ICRA]AA (Stable).

The letter states the rating is due for surveillance within one year from the date of the rating communication letter.

ICRA reserves the right to review or revise the rating at any time based on new information.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
11 Aug 2025acquisition
Acquisition, Capex
Rainbow Childrens Medicare Limited has informed the Exchange about Acquisition
AI summary

Board approved execution of a Securities Subscription Agreement and Shareholders' Agreement to acquire 76% of fully diluted equity share capital and 100% of NCRPS of Pratiksha Women & Child Care Hospital Private Limited, a 150-bed hospital in Guwahati, Assam (100 beds operational, 50 more within 6 months).

Cash consideration: about Rs. 129.96 crore for the 76% equity stake and about Rs. 41.04 crore for the NCRPS; press release states enterprise valuation of about INR 171 crore, funded from cash reserves and internal accruals.

Completion is indicated within 30 days; no governmental or regulatory approvals are required; the acquisition is not a related party transaction.

Management (Dr. Ramesh Kancharla, Chairman & Managing Director) said the deal marks entry into the Northeast and the hospital will be rebranded as Pratiksha Rainbow Children's Hospital.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
04 Aug 2025transcript
Acquisition, Capex, Dividend / buy-back, Guidance, Results
Rainbow Childrens Medicare Limited has informed the Exchange about Transcript
AI summary

Rainbow Children's Medicare filed the transcript of its Q1 FY26 investor call held on July 28, 2025, under Regulation 30.

Management said revenue grew 7% to INR353 crores, EBITDA rose 11% to INR103.6 crores (29.4% margin), and PAT rose 35% to INR53.8 crores; occupancy was 40.2%.

Management said it acquired a 76% majority stake in Prashanthi Hospital Warangal and that the company held net cash of INR735 crores as of June 30, 2025.

Management said the Pune 150-bed greenfield project was in advanced discussions and that the Rajahmundry hospital awaited final government permissions.

Management said about INR41.5 crores was invested in capex during the quarter and that the AGM was held on July 5, 2025, with dividend credited the same day.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
26 Jul 2025board outcome
Management change, Results
Rainbow Childrens Medicare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
AI summary

Rainbow Children's Medicare Limited filed the outcome of its board meeting held July 26, 2025, approving unaudited standalone and consolidated results for the quarter ended June 30, 2025.

Standalone revenue from operations for Q1 FY26 was Rs. 3,347.48 million, against Rs. 3,150.23 million in the year-ago quarter (June 30, 2024).

Standalone profit after tax was Rs. 517.20 million, against Rs. 387.27 million a year earlier; basic EPS was Rs. 5.09 versus Rs. 3.82.

The board also designated Dr. Pranathi Subrahmanyam Maddirala, Clinical Director of Obstetrics and Fetal Medicine, as Senior Management Personnel with immediate effect.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
26 Jul 2025presentation
Results
Rainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation
AI summary

Rainbow Children's Medicare Limited filed its earnings presentation on the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY25-26), to be shared with analysts and investors.

The presentation highlights the Company as the country's largest pediatric hospital chain, with 20 hospitals across 7 cities (the document lists 201 hospitals in one place and 20 hospitals in another; the footprint slide shows hospitals 20, cities 5 and clinics 7 as printed).

The Company cites its first pediatric hospital to have two flagship hub hospitals in Hyderabad and Bengaluru accredited by JCI, and its BirthRight Fertility centre in Kondapur, Hyderabad re-accredited by JCI.

Q1 FY26 footprint figures shown: 925+ doctors, 3.9k+ capacity beds, 329k+ outpatient visits, 20.9k+ deliveries and 2,035 in-patient admissions.

The presentation includes no financial figures for revenue or profit in the pages provided.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
26 Jul 2025board outcome
Management change, Results
Rainbow Childrens Medicare Limited has informed the Exchange regarding Board meeting held on July 26, 2025.
AI summary

Board of Rainbow Children's Medicare Limited approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, with a limited review report from S.R. Batliboi & Associates LLP.

Standalone revenue from operations for Q1 FY26 was Rs 3,347.48 million, against Rs 3,150.23 million in the year-ago quarter; total income was Rs 3,540.33 million.

Standalone profit after tax was Rs 517.20 million, against Rs 387.27 million a year earlier; basic EPS was Rs 5.09.

The Board also designated Dr. Pranathi Subrahmanyam Maddirala, Clinical Director of Obstetrics and Fetal Medicine, as Senior Management Personnel with immediate effect.

The board meeting ran from 2:15 P.M. to 3:15 P.M. on July 26, 2025.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
28 Jun 2025acquisition
Acquisition
Rainbow Childrens Medicare Limited has informed the Exchange about Acquisition
AI summary

Rainbow Children's Medicare's Business Strategy & Investment Committee approved, on June 28, 2025, execution of a Share Subscription Agreement and Shareholders' Agreement to acquire 76% of fully diluted equity share capital and 100% of NCRPS of Prashanthi Medicare Private Limited (Prashanthi Hospital), a 100-bed hospital at Warangal, Telangana.

Consideration is cash: about Rs. 24.85 crore for the 76% equity stake and about Rs. 7.75 crore for the NCRPS; enterprise valuation is about INR 32.60 crore, about 9 times estimated FY25 adjusted EBITDA.

The acquisition is expected to complete within 30 days; no governmental or regulatory approvals are required, and it is not a related party transaction.

Per the release, management (Chairman & MD Dr. Ramesh Kancharla) said the deal deepens the company's presence in Telangana, and the hospital will be rebranded and integrated into the hub-and-spoke network, taking total capacity to 2,035 beds across 20 hospitals in 7 cities.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
31 May 2025transcript
Capex, Guidance, Results
Rainbow Childrens Medicare Limited has informed the Exchange about Transcript
AI summary

Rainbow Children's Medicare filed the transcript of its Q4 FY25 earnings investor call held on May 26, 2025.

Management said Q4 revenue grew 8.5% to INR 370.1 crores, EBITDA rose 8.7% to INR 114.7 crores and PAT grew 10.7% to INR 56.5 crores; full-year revenue was INR 1,515.9 crores (up 16.9%) and full-year PAT INR 244 crores (up 11.9%).

Management said Q4 was an unusually quiet season with about 35% of the business subdued, and international revenue for the year was INR 30.7 crores versus INR 44 crores last year.

Management said full-year capex was INR 145.7 crores, cash of close to INR 700 crores as of March 31, 2025 supports planned capex through internal accruals, and it guided to a minimum pre-Ind AS EBITDA margin of 25% for FY26.

Management said about 250 new beds are to be added over the next six months, including Rajahmundry, Hennur and Electronic City hospitals.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
24 May 2025presentation
Results
Rainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation
AI summary

Rainbow Children's Medicare Limited filed its earnings presentation on the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025, which it proposes to share with analysts and investors.

The pages provided cover company background, awards and JCI accreditations, corporate history and footprint, but do not include the financial figures.

FY25 footprint as printed: 19 hospitals across 6 cities, 910+ capacity beds, 1,935 doctors, 1,426k+ outpatient visits, 98k+ deliveries and 17k+ in-patient admissions.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
24 May 2025dividend
Dividend / buy-back, Results
Rainbow Childrens Medicare Limited has informed the Exchange that Board of Directors at its meeting held on May 24, 2025, recommended Final Dividend of 3 per equity share.
AI summary

Rainbow Children's Medicare Limited filed the outcome of its board meeting held May 24, 2025, approving audited standalone and consolidated results for the quarter and financial year ended March 31, 2025, with an unmodified auditor's opinion from S.R. Batliboi & Associates LLP.

The board recommended a final dividend of ₹3 per equity share (30% on face value of ₹10), subject to shareholder approval at the 27th AGM on July 5, 2025.

June 28, 2025 is fixed as the record date for the final dividend; payment to be made within 30 days of the AGM.

The board appointed K.V.S. Subramanyam as Secretarial Auditor for five years from FY 2025-26, re-appointed Deloitte Touche Tohmatsu India LLP as Internal Auditors for FY 2025-26 and 2026-27, and re-appointed Lavanya & Associates as Cost Auditors for FY 2025-26.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
24 May 2025board outcome
Dividend / buy-back, Results
Rainbow Childrens Medicare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
AI summary

Rainbow Children's Medicare Limited filed the outcome of its board meeting held on May 24, 2025, which approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, with an unmodified auditor's report from S.R. Batliboi & Associates LLP.

The board recommended a final dividend of ₹3 per equity share (30% on face value of ₹10) for FY 2024-25, subject to shareholder approval at the 27th AGM on July 5, 2025, with record date June 28, 2025.

The board appointed K.V.S. Subramanyam as Secretarial Auditor for five years from FY 2025-26, re-appointed Deloitte Touche Tohmatsu India LLP as Internal Auditors for FY 2025-26 and 2026-27, and re-appointed Lavanya & Associates as Cost Auditors for FY 2025-26.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
15 Feb 2025transcript
Capex, Guidance, Results
Rainbow Childrens Medicare Limited has informed the Exchange about Transcript
AI summary

Rainbow Children's Medicare filed the transcript of its Q3 & 9M FY25 investor call held on February 10, 2025.

Management reported Q3 FY25 revenue of INR398 crores (up 18.5%), EBITDA of INR134.3 crores (up 14%) and PAT of INR68.9 crores (up 10.2%); 9M revenue was INR1,146 crores (up about 20%) and 9M PAT INR188 crores (up 12.2%).

Management said international business is facing headwinds in countries such as Bangladesh, Oman, Kenya and Sudan, and it now makes up about 2% of total business in Q3.

Management stated net cash of INR667 crores as of December 31, 2024, and expects to fund planned capex through internal accruals without debt; Q3 capex was about INR22 crores.

Management said a regional hub hospital in Rajahmundry is expected to start operations by May 2025, and about 1,000 beds are planned over the next 3.5 years.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
10 Feb 2025results
Results
Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024
AI summary

Rainbow Children's Medicare Limited filed its integrated filing (financial) for the quarter and nine months ended 31 December 2024, including unaudited standalone results reviewed by the statutory auditors (S.R. Batliboi & Associates LLP).

Q3 FY25 (quarter ended 31 Dec 2024) revenue from operations was Rs. 3,815.65 million versus Rs. 3,217.90 million in the year-ago quarter; profit after tax was Rs. 669.75 million versus Rs. 611.41 million; basic EPS was Rs. 6.60 versus Rs. 6.03.

Nine-month revenue from operations was Rs. 11,005.12 million versus Rs. 9,108.05 million; nine-month profit after tax was Rs. 1,830.45 million versus Rs. 1,644.55 million; nine-month basic EPS was Rs. 18.03 versus Rs. 16.20.

The filing also reports IPO proceeds utilisation: of Rs. 2,661.40 million net fresh issue proceeds, Rs. 2,559.81 million was utilised up to 31 December 2024, leaving Rs. 116.29 million unspent.

The results were approved by the Board on 9 February 2025.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
09 Feb 2025presentation
Results
Rainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation
AI summary

Rainbow Children's Medicare Limited filed its earnings presentation on the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024 (Q3 FY24-25), dated February 9, 2025, to be shared with analysts and investors.

The presentation pages provided cover the company's history, awards and accreditations (including JCI accreditation for its pediatric hospitals and BirthRight Fertility), and a description of the company as the country's largest pediatric hospital chain with 19 hospitals across 6 cities.

The pages provided do not include the financial figures or management commentary on results.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
09 Feb 2025results
Dividend / buy-back, Management change, Results
Rainbow Childrens Medicare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
AI summary

Board of Rainbow Children's Medicare Limited met on February 9, 2025 and approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, with Limited Review Reports from statutory auditors S. R. Batliboi & Associates LLP.

The Board appointed Ms. Shreya Mitra as Company Secretary & Compliance Officer (Key Managerial Personnel) with effect from February 9, 2025.

The Board approved formulation of the "Rainbow Children's Medicare Limited - Employee Stock Option Scheme 2025" for grant of not exceeding 10,15,000 stock options, subject to shareholder and other approvals.

The Board authorised Dr. Ramesh Kancharla, Vikas Maheshwari and Shreya Mitra to determine materiality of events under Regulation 30(5) of the Listing Regulations.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
09 Feb 2025board outcome
Legal, Management change, Results
Rainbow Childrens Medicare Limited has informed the Exchange regarding Board meeting held on February 09, 2025.
AI summary

Board of Rainbow Children's Medicare Limited approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, with limited review reports from S. R. Batliboi & Associates LLP enclosed.

Board appointed Ms. Shreya Mitra (ICSI Membership No: A54901) as Company Secretary & Compliance Officer (Key Managerial Personnel) effective February 9, 2025.

Board approved formulation of "Rainbow Children's Medicare Limited - Employee Stock Option Scheme 2025" for grant of not exceeding 10,15,000 stock options to eligible employees of the company and its subsidiaries, subject to shareholder and other approvals.

Board authorised Dr. Ramesh Kancharla, Mr. Vikas Maheshwari and Ms. Shreya Mitra to determine materiality of events or information under Regulation 30(5) of the Listing Regulations.

The board meeting commenced at 3:00 P.M. and concluded at 5:00 P.M.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
07 Jan 2025credit rating
Rating
Rainbow Childrens Medicare Limited has informed the Exchange about Credit Rating- Others
AI summary

Rainbow Children's Medicare Limited filed a credit rating disclosure under Regulation 30 of the SEBI LODR Regulations, dated January 7, 2025.

ICRA Limited reaffirmed the company's issuer rating at [ICRA]AA (Stable), the same rating as assigned previously.

The rated amount is shown as Rs. 0.00 crore, with the rating covering the issuer.

The rating is due for surveillance within one year from the date of the rating communication letter.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy

The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in